Spiriva Respimat (tiotropium bromide) - Boehringer Ingelheim
PRETIO: PREterm Infants With Bronchial Obstruction - Prospective Study of Efficacy and Safety of Inhaled Tiotropium (clinicaltrials.gov) - Sep 19, 2026 - P4 | N=50 | Not yet recruiting | Sponsor: General University Hospital, Prague 
New P4 trial
http://clinicaltrials.gov/ct2/show/NCT07827859
 
Sep 19, 2026
 
Prev Next